肌酐
来复枪
医学
急性肾损伤
肾脏疾病
危险系数
置信区间
内科学
重症监护医学
历史
考古
作者
Xin Xu,Sheng Nie,Aihua Zhang,Jianhua Mao,Haipeng Liu,Huimin Xia,Hong Xu,Zhangsuo Liu,Shipin Feng,Wei Zhou,Xuemei Liu,Yonghong Yang,Yuhong Tao,Yunlin Feng,Chunbo Chen,Mo Wang,Yan Zha,Jianhua Feng,Qingchu Li,Shuwang Ge
出处
期刊:Journal of The American Society of Nephrology
日期:2018-07-27
卷期号:29 (9): 2432-2442
被引量:91
标识
DOI:10.1681/asn.2018010090
摘要
Background Current definitions of AKI do not take into account serum creatinine’s high variability in children. Methods We analyzed data from 156,075 hospitalized children with at least two creatinine tests within 30 days. We estimated reference change value (RCV) of creatinine on the basis of age and initial creatinine level in children without kidney disease or known AKI risk, and we used these data to develop a model for detecting pediatric AKI on the basis of RCV of creatinine. We defined pediatric AKI according to pediatric reference change value optimized for AKI in children (pROCK) as creatinine increase beyond RCV of creatinine, which was estimated as the greater of 20 μ mol/L or 30% of the initial creatinine level. Results Of 102,817 children with at least two serum creatinine tests within 7 days, 5432 (5.3%) had AKI as defined by pROCK compared with 15,647 (15.2%) and 10,446 (10.2%) as defined by pediatric RIFLE (pRIFLE) and Kidney Disease Improving Global Outcomes (KDIGO), respectively. Children with pROCK-defined AKI had significantly increased risk of death (hazard ratio, 3.56; 95% confidence interval, 3.15 to 4.04) compared with those without AKI. About 66% of patients with pRIFLE-defined AKI and 51% of patients with KDIGO-defined AKI, mostly children with initial creatinine level of <30 μ mol/L, were reclassified as non-AKI by pROCK, and mortality risk in these children was comparable with risk in those without AKI by all definitions. Conclusions pROCK criterion improves detection of “true” AKI in children compared with earlier definitions that may lead to pediatric AKI overdiagnosis.
科研通智能强力驱动
Strongly Powered by AbleSci AI